Aurobindo Pharma Limited has informed the Exchange about Copy of Newspaper Publication
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has submitted copies of a newspaper notice published on February 13, 2026, in Business Standard (English) and Nava Telangana (Telugu) to NSE and BSE. The notice informs shareholders about a special window for re-lodgement of transfer requests for physical shares. The filing was made by B. Adi Reddy, Company Secretary, as a routine regulatory disclosure. No new financial, business, or strategic information was disclosed. The remaining content in the document appears to be unrelated notices from other entities (NSE delisting notice, SECI tender, CESC NIT) published in the same newspaper editions.
This is a routine procedural filing with no direct impact on the company's financials, operations, or stock price. Shareholders with pending physical share transfer requests should check the original newspaper notice for the deadline and procedure to re-lodge their requests.